Personalizing brain stimulation for epilepsy

Optimizing Neuromodulation Therapies for Epilepsy: Identifying the Right Patient, Right Place, and Right Time for Stimulation

NIH-funded research Brigham and Women's Hospital · NIH-11239022

This project will find ways to personalize responsive brain stimulation so people with drug-resistant epilepsy have better seizure control.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-11239022 on NIH RePORTER

What this research studies

If you have hard-to-treat epilepsy, researchers will use your brain scans and data from responsive neurostimulation (RNS) devices to map the brain networks linked to good responses. They will combine patient-specific white-matter connectivity, structural imaging, and models of how stimulation spreads in the brain to pinpoint the best targets. The team will look at when stimulation is delivered, testing whether delivering pulses during periods of low seizure risk improves long-term outcomes. They will also study natural daily (circadian) rhythms in brain activity to see if those patterns predict who benefits most, with the goal of guiding new closed-loop stimulation approaches.

Who could benefit from this research

Good fit: Adults with medically refractory focal epilepsy who have or are candidates for responsive neurostimulation (RNS) are the most likely participants.

Not a fit: People with seizure types that are generalized, those well-controlled on medication, young children not eligible for RNS, or anyone who cannot undergo required imaging or device follow-up may not benefit from this work.

Why it matters

Potential benefit: If successful, this work could help more people with medication-resistant epilepsy get faster and more complete seizure control by tailoring stimulation to each person.

How similar studies have performed: Responsive neurostimulation has helped many patients achieve significant seizure reduction, but personalizing target networks and timing of stimulation is a newer approach that remains less tested.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.